SONDALO COURSE 57th Edition
End TB strategy and TB elimination during/after COVID-19 pandemic:
from guidelines to implementation
May 23 - 28, 2022
ATTENTION: IMPORTANT NOTE
Due to the persistent global COVID-19 threat (and consequent restrictions) the face-to-face course, originally scheduled for May 8-21, has been canceled.
The overall goal of the training course is to further develop the necessary skills to plan, implement and evaluate a TB control programme during and after the COVID-19 pandemic, based on the WHO End TB Strategy, with a special focus towards TB Elimination. The course uses innovative approaches, taking advantage of core WHO guidelines and other guidance documents, and simulation activities centred around Fictitia (a fictitious country in which all activities take place). The course is interactive and exercise based, being a mixture of state-of-the –art presentations based on guidelines, role plays, problem-solving exercises and forums with experts.
The course covers the following topics:
• End TB Strategy: prevention, diagnosis and treatment
• Universal health coverage and policy frameworks for social protection and poverty alleviation;
• TB Epidemiology and TB Elimination
• Recording and reporting, case notifications (including evaluation of treatment outcomes and drivers identification)
• TB during and after the COVID-19 pandemic: effect of co-infection and impact of TB health services
• TB in migrants and vulnerable populations
• TB/HIV collaborative activities
• Role and functions of a National TB programme
• Managing TB Infection
• Systematic screening and intensified case-finding
• Laboratory diagnosis and treatment; integrated patient-centred care
• Managing MDR-/XDR-TB
• Involving the private sector (PPM)
• Drug supply and management and pharmacovigilance
• Supervision, planning and programmatic management
• Infection control
• Monitoring, evaluation and planning
• Intensified Research and Innovation
Simulation exercises for the core topics
The Sondalo course is composed of three parts.
Part 1: Introduction.
This part includes presentation of aim and goals, existing definitions and all the preliminary aspects related to the preparation of a mission to Countries and to the Report to the funding Agency, as well as the history and evolution of the WHO Strategies to prevent, diagnose and treat tuberculosis.
Part 2: Implementation of the End TB Strategy control and elimination strategy (End TB)
This part revises in a practical and interactive manner how to implement the three Pillars of the WHO End TB Strategy (I: Integrated patient-centred care; II: Bold Policies and supportive systems; III: Intensified research and Innovation). Moving from the core technical interventions (early diagnosis- including universal drug susceptibility testing, systematic screening of contacts and high risk groups; treatment of all people- including those affected by drug-resistant TB ad co-infected by HIV, and those with co-morbidities and prevention interventions), the course goes deeply into policies and supportive systems (political commitment and adequate resources; engagement of communities, civil society organizations and public and private providers; universal health coverage and policy frameworks for case-notifications, vital registration, drug quality, rational use of drugs and diagnostics and infection control; social protection and poverty alleviation) to finally discuss the process supporting discovery, development and rapid uptake of new diagnostics and drugs as well as interventions and strategies.
Part 3: Planning and M&E of the TB Control and Elimination Strategy in Fictitia.
This part will be focused on Planning and Monitoring and Evaluation.
Participants will be guided to: 1) use the WHO Planning toolkit for TB control, developed to help countries to design core plan, budget plan, M&E plan, operational plan and technical assistance plan. 2) interact with the new GF funding model.
It will also include evaluation of the Reports on the mission to Fictitia (participants will be asked to produce on site) and of the plans on MDR-/XDR-TB, TB/HIV collaborative activities, PPM and infection control as well as the evaluation of the whole training course.
This course is designed for individuals responsible for planning, organizing, implementing and evaluating TB and MDR-TB control activities during/after the COVID-19 pandemic within the framework of the implementation of the End TB Strategy, at national and sub-national level.
They might be managers or consultants of TB/MDR-TB and HIV programmes at the national or sub-national level or staff otherwise involved in control programmes at national or sub-national level (Ministry of Health staff, staff of international agencies involved in TB/MDR-TB/HIV control, leading national experts and opinion-leaders involved in TB/MDR-TB/HIV & COVID-19 prevention, diagnosis and care).
This training course has been globally recognized and recommended as one of the best and complete training package available on TB management and control, giving a wide perspective on many different, updated hot topics (being also officially recognized as a pre-requisite to perform international consultancies in TB-related topics).
The course, considered to have an excellent value for money, allows participants to share their experience with a global perspective, opening also perspective for international consultancy.
Training format: 2 week, in-person course (face-to-face learning) based on work in small groups
Language: English (with tutoring in French, Spanish and Portuguese and possibility to have groups working in own language).
February 28, 2022
For further queries, details and information, please contact: